Geographic Atrophy study: JNJ-81201887
Official title A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
ClinicalTrials.gov ID: NCT06635148
What this study is testing
What is JNJ-81201887?
This is an investigational medicine being studied for geographic atrophy.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is looking at how safe the medicine is over time. It checks for any side effects after the first treatment.
- Who it's for
- You may be able to join if you already took part in an earlier study of this eye medicine.
- What's involved
- You would get a shot of medicine into your eye. The team will check your eyes to see how you are doing.
- Time commitment
- The study lasts a long time to watch for safety issues. You will need to come in for regular check-ups.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 and older
You may be able to join if
- Participants who were enrolled and received treatment with JNJ-81201887 or sham in a parent clinical study (81201887MDG2001, 81201887MDG1003)
- Females (women of childbearing potential), male participants, and partners of male participants will not be required to use contraception in this LTE...
- Must sign an informed consent form (ICF) indicating that participant understands the purpose of, and procedures required for, the study and is...
You likely can't join if
- There are no exclusion criteria for this LTE study
The study team makes the final eligibility decision.
Where it is enrolling
- Tucson, Arizona, United States
- Fullerton, California, United States
- La Jolla, California, United States
- Oxnard, California, United States
- Pasadena, California, United States
- Poway, California, United States
- Walnut Creek, California, United States
- Fort Lauderdale, Florida, United States
- Gainesville, Florida, United States
- Pensacola, Florida, United States
- St. Petersburg, Florida, United States
- Marietta, Georgia, United States
- Lemont, Illinois, United States
- Carmel, Indiana, United States
- Portland, Maine, United States
- Baltimore, Maryland, United States
- Chevy Chase, Maryland, United States
- Hagerstown, Maryland, United States
- Boston, Massachusetts, United States
- Grand Rapids, Michigan, United States
+ 56 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Tucson, Arizona, United States; Fullerton, California, United States; La Jolla, California, United States; Oxnard, California, United States; Pasadena, California, United States; Poway, California, United States and 70 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.